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Most, if not all, ingested protein is transported across the gut as
its constituent amino acids. Thus,
the way the gut handles amino
acids is an important physiologic
problem, and their mishandling by
the gut in disease states represents
an important threat to general
body activities. I propose to discuss some of the knowledge that
has been gathered over the past
10 to 15 years concerning the
mechanisms of amino acid absorption. The data to be presented have been gathered from
three major kinds of studies: the
studies of in vitro model systems,
physiologic studies of humans, and
studies of patients , with syndromes
involving specific amino absorption
abnormalities. Some of these data
have been accumulated in our own
laboratory; much of what I have
to present is the work of other
investigators.
In Vitro Studies on Gut
Figure 1 shows an experimental
technique which has become a
classic model for the study of
transport of various substances,
not only amino acids. This is the
everted gut sac. The technique involves making everted gut segments from the intestines of small
animals. The animal's gut is removed as quickly as possible,
cleaned, turned inside out so that
the mucosa is on the outside, and
small sacs made of the segments
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of the gut. The sacs are then placed
in various bathing solutions containing the substances to be tested.
Figure 2 shows the kinds of results one can obtain with this kind
of method. As indicated by the
dotted line, the concentration of
the substance tested, in this case
the amino acid, L-tryptophan, was
the same on both the mucosa! and
the serosal sides. The measurement
of the concentration changes at
various time intervals following the
placing of the substance in the sac
is an indication of what movement
is going on. Under aerobic conditions (the box on the left), the
mucosa! concentration of tryptophan (black column) decreased
after an hour's incubation, and the
serosal concentration increased.
Remember that the initial concentration was the same on both sides.
Anaerobically, when oxygen was
not allowed in the flask, concentration against a gradient no longer
occurred.
The importance of aerobic,
energy-dependent systems for
transport of L-tryptophan from the
mucosa! surface to the serosal side
is shown in Figure 3. In this study,
tryptophan initially was placed
only on the mucosa! side, in contrast to the previous study. None
was on the serosal side. After an
hour's incubation aerobically, not
only had some tryptophan been
transported from the mucosa! to
the serosal side, but there also
now existed a concentration gradient between these two sides. By
contrast, anaerobically the transfer from the mucosa! to serosal
side was very much diminished,

and no concentration gradient had
been developed.
Figure 4 shows an experiment
with a substance for which there
is no active transport mechanism.
The test substance was pyridoxine.
In the upper bar is shown the
situation when pyridoxine was
placed at equal concentration on
both sides of the everted gut sac.
There was no concentration gradient developed from the mucosa to
serosa either aerobically or anaerobically. The bottom set shows the
situation when the pyridoxine was
placed only on the mucosa! side.
Transfer was slow; no concentration gradient developed, and it did
not make any difference whether
the environment was anaerobic or
aerobic. This further confirms the
idea that energy-dependent systems
are of significance in transporting
tryptophan, whereas they are not of
significance in transporting pyridoxine.
By the use of this in vitro technique, unphysiologic as it may
sound, much information has been
gathered as to the transport of
amino acids. Table 1 shows some
data obtained with a series of
amino acids using the everted gut
sac technique. A concentration
gradient > 1.00, as indicated in the
third column, indicates that there
was accumulation of these amino
acids on the serosal side as compared to the mucosa! · side, the
amino acids having been in each
instance placed in equal concentrations on both sides of the membrane at the start of the experiment.
It is obvious that different amino
acids behave in somewhat different
21
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manners. In addition to testing
single amino acids, mixtures of
amino acids and amino acids in
which parts of the amino acid molecules have been modified have also
been studied.
On the basis of such studies in
the everted gut sac, it appears that
certain types of amino acids are
transported by specific mechanisms. It is presently thought that
there exist separate specific transport mechanisms for the monocarboxylic neutral amino acids; for
dibasic amino acids, such as lysine,
arginine, and ornithine along with
the neutral amino acid, cystine; for
the dicarboxylic amino acids; and,
possibly, for proline, hydroxyproline and, questionably, glycine.
Figure 5 shows a sketch of how
amino acids might interact with
a membrane carrier. This scheme
applies, most likely, to the neutral
amino acids. The carboxyl, the
hydrogen, and the alpha amino
groups all are quite specific, since
substitutions at any one of these
sites decrease the transport rate of
the amino acid. The question mark
next to the pyridoxal phosphate indicates that certain studies suggest
that this substance may be an important co-factor in neutral amino
acid transport. The longer the side
group, indicated here as the R, the
more lipophilic the substance is
and the greater the affinity of the
amino acid for the lipid carrier or
the lipid membrane. It has been
shown in the group of neutral
amino acids that those with a
longer side chain, i.e., those with
a more lipophilic side chain, compete preferentially for transport
with those with shorter side chains.
Thus, on the basis of these animal in vitro experiments, of which
this has been only a brief resume,
there has evolved a concept of
amino acid absorption as being
one in which there are several
specific carrier mechanisms involved.
Studies o n Human Gut
In order to study amino acid absorption in humans, different tech22

Fig. 1-Everted sac method of Wilson and Wiseman. Tied sac of everted
hamster jejunum containing 1 ml of fluid. X 2.64 (Reprinted with permission
from T. H. Wilson, Intestinal Absorption. Philadelphia: W. B. Saunders, 1962,
p. 33.)
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Fig. 2-Transport of SH-labelled L-tryptophan by everted loops of rat small
intestine. The interrupted line indicates initial concentration on both sides of
the sac. The final concentrations in each of two experiments are shown by the
columns. Note that at the end of one hour there· is a concentration gradient
between the inside of the sac .(serosal side) and outside (mucosa! side) when
incubation is aerobic. This does not occur anaerobically. (Reprinted with
permission from The Scientific Basis of Medicine Annual R eviews. London: The
Athlone Press, 1963, p. 172.)
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TABLE 1
Rates of Transference of Amino -Acids an{Concentration Gradients Developed
by Sacs of Everted Intestine
Rate of transference
(µl. / mg dry wt. / hr)

Amino Acid
Praline*
Threonine
Alanine
Glycine*
Serine
Valine
Histidine*
Hydroxyproline
Phenylalanine
lsoleucine

14.0
12.0
11.5
10.1
8. 8
8.2
5.3
6.3
5.4
4.0

±
±
±
±
±
±
±
±
±
±

Concentration gradient
developed

3.2
2.7
3.5
2.4
2.2
2.7
2.8
1.8
2.2
1.2

2.08
1.90
1.82
1.65
1.61
1.42
l.42
1. 36
l.24
1.19

±
±
±
±
±
±
±
±
±
±

0.18
0.28
0.32
0.19
0.19
0.19
0.22
0.14
0.11
0.09

* These results are taken from Wiseman (1955) and are included in this table
for the sake of completeness. The experiments were performed under identical
conditions.
Adapted with permission from J. Physiol. 133: 628, 1956.

AEROBIC

ANAEROBIC

40

E
..__

20

INITIAL
MUCOSAL
CONCE.NTRATION

-

Cl

::i.

0

D

Se ro so l

•

M u co sa !

Tim e ' I hou r

Fig. 3- Typical everted loop experiments using "H-labelled L-tryptophan initially
on the _outside of the sac (mucosa! side) only. Aerobically active transport
r:sult~ m the development of a concentration gradient. Anaerobically only
d1ffus1on occurs. (Reprinted with permission from The Scientific Basis of Medicine Annual Reviews. London: The Athlone Press, 1963, p. 173.)

niques must be developed. Aside
from the difficulty of obtaining
pieces of human gut to make
everted gut sacs, such sacs could
not be used in the same way as
sacs from hamster gut. Besides possible species differences in transport, from the practical standpoint
there is the fact that, in the larger
species, such as dog, the muscle
wall is so thick that penetration of
substance from mucosa through to
the serosal side is ineffective. In humans two major kinds of approaches
have been used. One method is to
take pieces of gut at operations, or
by biopsy, and perform in vitro
studies. I shall discuss these studies
later, mainly in regard to certain
disease states. Another method is
to perfuse the gut under more or
less physiologic conditions. Perfusion experiments . to study intestinal absorption of amino acids
and other substances in the human
have been widely used. In general
the method is as follows: A subject is intubated with a tube which
most often contains two holes, a
perfusing hole and an aspirating
hole, some distance down the gut.
The test substance is then perfused along with a non-absorbable
reference marker, polyethylene
glycol being one that is commonly
and popularly used today. The disappearance from the gut lumen of
the substance to be studied in relation to · changes in marker concentration as a measure of water
absorption has been used as a test
for absorption of the specific substance being studied. Thus, if the
concentration of amino acids drops
during the test, in relation to the
concentration polyethylene glycol,
some of the amino acid has been
absorbed during the period of perfusion.
Table 2 shows the kind of data
obtained when the absorption of
glycine was studied by the perfusion method. As the glycine concentration in the perfusion fluid was
increased, the amount absorbed, ex23
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pressed as millimoles per 15-centimeter gut segment perfused, also
increased. The increase in the
amount absorbed, however, was
not linearly related to the increase
in the glycine concentration of the
perfusion fluid. The rate of glycine
absorption reached a limiting
value. This is illustrated in Figure
6, which shows the results of
studies of L-isoleucine absorption
in two subjects. Plotted are millimoles absorbed against the concentration of isoleucine perfused.
As the concentration increased, the
amount absorbed also increased,
but the absorption rate tailed off as
the concentration increased. If
simple diffusion were the process
involved, one would expect a
straight-line relationship between
the concentration perfused and the
amount absorbed. Instead, this
curve suggests saturation kinetics
and is, thus, consistent with the
idea that some sort of active transport process is taking place.
Figure 7 shows the results of
transport fluids in which the gut
was perfused with solution containing both glycine and L-alanine.
At the bottom of Figure 7 are indicated the concentrations of each
substance for any one study. For
example, "fifty" means that a 50
mM solution of glycine and a 50
mM solution of L-alanine were perfused together. Three patients were
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Fig. 4-Everted loop experiments using 0 H-labelled pyridoxine HCI. The
interrupted line indicates the initial concentrations. With equal concentrations
on both sides of the sac initially (upper figure), there is no active transport for
no concentration gradient develops. When pyridoxine is only present on the
outside (lower figure), it diffuses across into the serosal fluid equally well
whether incubation is aerobic or anaerobic. (Reprinted with permission from
The Scientific Basis of Medicine Annual Reviews. London: The Athlone Press,
1963, p. 174.)

TABLE 2
Absorption of Glycine
Perfused (mM)

10

25
50

75
100
150
300

Absorbed
(mmoles / 15
min / 15-cm
gut segment)
1
3
3
6
7
10
15

± 0
± 1
± 1
± 1
± 1
± 3
± 4

Adapted with permission from
J. Clin. Inv. 45: 1435, 1966.
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Fig. 5-Hypothetical interaction of neutral amino acid with the membrane
carrier. (Reprinted with permission from T. H. Wilson, Intestinal Absorption.
Philadelphia: W. B. Saunders, 1962, p. 123.)
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studied, and on each several experiments were performed. It can
be seen that, at every concentration
studied, the absorption of alanine,
shown by clear bars, was always
greater than the absorption of glycine. If passive diffusion process
alone were involved, the two substances would not be expected to
so drastically influence each other's absorption.
Another way of testing whether
or not substances share a common
site for absorption involves holding the concentration of one substance constant but changing the
concentration of the other substance. The first is then called the
inhibitor; the second , the test substance. Figure 8 shows a Lineweaver-Burk plot, a double reciprocal plot in which l / S is the
reciprocal of the concentration perfused, and 1/V represents the reciprocal of the amount absorbed .
The solid line connecting these
open circles indicates the absorption of glycine at various concentrations when perfused alone. The
dotted line indicates the absorption
of glycine in the same subject when
perfused at various concentrations
together with 150 mM L-alanine as
the inhibitor. This line is displaced
upwards and to the left; in other
words, the absorption of glycine
is decreased in the presence of
the inhibitor, L-alanine. However,
as the concentration of glycine is
increased, the line tends to meet
the line representing absorption of
glycine alone; it intercepts the vertical axis at the same place. The
fact that the lines under these two
conditions arrive at the same point
is consistent with a form of inhibition called competitive inhibition, that is, where two substances
compete for the same transport
mechanism or for the same binding site. If the inhibition were not
competitive, that is, if the binding
site were being poisoned in some
way by the inhibitor, then the intercepts would not be expected to
be at the same place. These studies
in humans with glycine and alanine
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Fig. 6-Plots of L-isoleucine absorption (mmole/ 15 min/ 15-cm gut segment)
against concentration of isoleucine perfused. The results obtained on two human
subjects with intubation tubes for perfusion are shown.
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Fig. 7- Absorption of glycine and L-alanine when perfused together at
equimolar concentrations. The first three studies (starting at the left) were
performed in Subject 1, the fourth in Subject 2, and the last three in Subject 3.
In the first study, perfusate osmolality was 245 mOsm per kg and in the last
two studies, 396 and 620 mOsm per kg, respectively. The height of the column
indicates mean absorption. (Reprinted with permission from J. Clin. Inv .
45: 1436, 1966.)
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are, thus, consistent with the
studies in everted gut sacs in in
vitro preparations. They indicate
that these particular amino acids
are absorbed by active transport
mechanisms.
The influence of the lipophilic
side chain, suggested by the everted
gut sac experiments, can also be
seen when three amino acids are
tested together. Figure 9 shows the
results of perfusing together at
equimolar concentrations: isoleucine, alanine, and glycine. Isoleucine was always absorbed faster
than alanine, which, in turn, was
always absorbed faster than the
glycine.
On the basis of these studies
and the everted gut sac studies, one
would then predict that L-isoleucine
would be a very effective inhibitor
of glycine absorption. Surprisingly,
however, this was not found. Figure
10 shows Lineweaver-Burk plots of
glycine absorption. The solid line
indicates glycine absorption when
glycine alone was perfused. The
small-dash line indicates the effect
of 150 mM alanine; the large-dash
line is the effect of isoleucine as an
inhibitor at 150 mM. No inhibitory
effect by the L-isoleucine on glycine absorption was seen. Isoleucine, as indicated previously, certainly is transported more quickly
than is glycine. These studies show
that isoleucine is not, however, as
effective an inhibitor of glycine absorption as is alanine. This might
well indicate that there are two
steps in amino acid transport. One
would be a postulated entry step
in which the length of the lipophilic chain is important and in
which the longer side chain of
isoleucine produces greater affinity
with the lipid membrane, enabling
it to be transported more quickly.
The second step, perhaps an exit
step, may be the specific carrier
mechanism and, indeed, may be
the rate-limiting step for the process. Isoleucine and glycine do not
appear to share this later step.
26
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permission from J. Clin. Inv. 45 : 1437, 1966.)
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In Vitro Studies on Gut Mucosa
In vitro studies on the distribution ratios of amino acids between
gut mucosa and bathing solution
may shed additional light on specific transport mechanisms for certain amino acids. Results obtained
from such studies are shown in
Table 3. By distribution ratio is
meant the concentration of amino
acid taken up by the mucosa in
relation to the concentration in
the bathing fluid. A distribution
ratio > 1.00 indicates that tissue
accumulated amino acids. For instance, when lysine alone was incubated with the tissue, the distribution ratio was 4.57 ± 1.84. When
lysine was incubated together with
either arginine or cystine, the distribution ratios found were considerably and statistically decreased as
compared to the situation when lysine alone was incubated. Glycine
incubated together with lysine had
no effect on lysine uptake by the
tissue, indicating that lysine, arginine, and cystine very likely form
one family, glycine not being part
of that family. Cystine incubated
alone gives a distribution ratio of
3.6 1 ± 0.85. When incubated together with lysine as the inhibitor,
the distribution ratio is less. Glycine
again has no effect on cystine distribution in the tissue.
Thus, many interesting results
have already been obtained from
in vitro studies and studies on
normal humans in regard to amino
acid absorption of the gut. Much
remains to be learned about the
normal processes by which amino
acids are handled by the gut. The
fact that various mixtures of amino
acids may be handled differently
can be of considerable metabolic
significance, since it has been
shown that lack of certain amino
acids in the diet results in poor
growth rates and poor wound healing rates. It appears that the body
has to be presented with certain
optimum mixtures of amino acids
for optimum function . With this,
then, as some indication of what
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TABLE 3
Inhibition of Normal Gut Mucosa! Uptake of L-Lysine-C 14 and L-Cystine-S 3'
by a Second Amino Acid
Distribution
Ratio

Significance of difference from control (p)

±
±
±
±

< 0.001
< 0.001
> 0.6

Substrate

Inhibitor

No. of Tests

L-lysine
L-lysine
L-lysine
L-lysine

None
L-arginine
L-cystine
Glycine

12
4
4
3

4.57
1.13
1.77
4.81

L-cystine
L-cystine
L-cystine

None
L-lysine
Glycine

10

3.61 ± 0.85
2.31 ± 0.35
3.63 ± 0.96

4
3

1.84
0.22
0.26
0.40

< 0.01
> 0.9

Adapted with permission from Science 143: 483, 1964.
Copyright by the American Association for the Advancement of Science.

27

AMINO-ACID ABSORPTION
TABLE 4
Uptake of L-Lysine-cu and L-Cystine-S 36 by Gut Mucosa from Normal Subjects
and Patients with Cystinuria
Distribution Ratio (Mean ± SD)
L-lysine
Normal subjects
Cystinuric subjects

1.4 ± 0.26

L-cystine
4.5 ± 1.26
1.2 ± 0.28

(p < 0.001)

(p < 0.001)

13.4 ± 1.91

Adapted with permission from Science 143: 483, 1964.
Copyright by the American Association for the Advancement of Science.

TABLE 5
Evidence Favoring a Jejuna! Transport Defect for Tryptophan in Hartnup
Disease
Ingested L-tryptophan can be recovered in feces of patients but not of
normal subjects.
2. Plasma levels of tryptophan after ingestion of the amino acid rise more
slowly and remain high for a longer time in cases of Hartnup disease than
in normal subjects.
3. Bacterial breakdown products of tryptophan are excreted in greater amounts
and for longer periods after ingestion of the amino acid in Hartnup disease
patients than in normal subjects.
1.

Adapted with permission from Quart. J. Med. 29: 415, 1960.

TABLE 6
Evidence Concerning a Defect of Tryptophan Absorption in the Blue Diaper
Syndrome
1. Tryptophan content of stools, before and after loading with tryptophan,

higher in patients than controls.
2. Excess urinary excretion of indolic metabolites, especially after tryptophan
feeding, formed in lower gut by action of bacteria on unabsorbed tryptophan.
3. I. V. tryptophan in patient increased metabolites of kynurenine pathway
several times as compared to similar amounts of oral tryptophan. No such
discrepancy between oral and I. V. doses found in controls.
4. Plasma tryptophan levels following oral loading low in patients compared
with controls.
Compiled with permission from Quart. J . Med. 29 : 407-421, 1960.
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the state of the art is at the
moment insofar as amino acid under normal conditions is concerned, let us turn briefly to some
abnormalities of amino acid absorption.

Abno rmalities of Amino Acid
Absorption

Cystinuria
The first entity to be discussed
is cystinuria. This is a genetically
determined disorder in which the
outstanding clinical manifestation
is the formation of cystine renal
calculi. It has been known that
aminoaciduria occurs in cystinuric
patients. Only over the last few
years, however, has it been determined that a specific amino acid
transport defect can also be seen
in the gut. The results of in vitro
studies with isotopically labeled
lysine and cystine incubated with
gut mucosa obtained from cystinuric and normal subjects are shown
in Table 4. The amino acid distribution ratios in the gut of normal
subjects were considerably and statistically significantly higher than
the distribution ratios seen when the
gut mucosa of cystinuric subjects
was used. Thus, cystinuric gut mucosa has a specific defect for concentrating these particular amino
acids. The defect in cystinuria is
confined to the basic amino acids,
since other amino acids that have
been studied do not show the transport difficulties.
Another way of studying the
amino acid absorption defect in
cystinuria is to follow the fate of
ingested ornithine and lysine. When
this was done, amino acid was
found in the stool, and various
breakdown products of the amino
acids were found in both the feces
and the urine. In normal subjects,
feeding of these amino acids was
not
accompanied
by
similar
changes. These findings indicate
that, in cystinuria, the amino acids
are inefficiently absorbed by the
small bowel and, thus, can be acted
on by colonic bacteria. Thus, both
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by in vitro experiments with gut
mucosa! biopsies and by feeding
of amino acids, it can be demonstrated that there is a defect in
handling of basic amino acids by
patients with cystinuria.

'1000
Hartnup Disease

Another disorder in which a defect in amino acid absorption can
be demonstrated is a rare genetic
disorder named Hartnup disease.
This disorder is characterized by
a pellagra-like skin rash, a severe
but reversible cerebellar ataxia,
various psychiatric manifestations,
and an aminoaciduria involving alanine, serine, threonine, and a
number of other amino acids. Glycine, aspartic acid, glutamic acid,
lysine, arginine, and ornithine are
excreted in normal amounts in
Hartnup disease. Some observations
concerning gut absorption abnormality in Hartnup disease are summarized in Table 5. Ingested tryptophan can be recovered in the
feces of patients but not of normal
subjects. After ingestion of the
amino acid, plasma levels of tryptophan rise more slowly and remain
high for a longer time in cases of
Hartnup disease than in normal
subjects. Furthermore, after ingestion of the amino acid, bacterial
breakdown products of tryptophan
are excreted in greater amounts and
for a longer period in Hartnup
disease patients than in normal
subjects. These findings could be
explained by an enzymatic block
along the metabolic sequence from
tryptophan to nicotinic acid or by
an abnormal intestinal environment
supporting a peculiar gut flora
which deranged the metabolism of
the host. The most likely explanation, however, is that the kidney
and the gut share a metabolic abnormality for the transport of
amino acids. Certainly furhetr
studies need to be done before this
hypothesis can be accepted.
Except for the deficiency of
nicotinic acid and the production
of the pellagra-like rash in Hartnup disease, the effect of amino
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acid absorption deficiency in both
Hartnup disease and cystinuria is
not presently clear on a clinical
basis. It has been suggested that
growth may be retarded in these
patients, and calculations of the
amount of amino acid lost in the
urine and potentially unabsorbed
indicate that the amino acid intake
may be marginal. This may be
particularly true for lysine, which
is a limiting amino acid in many
nutritional studies.
Blue Diaper Syndrome

Another disorder in which there
also appears to be a defect in
tryptophan absorption is the socalled Blue Diaper Syndrome, a
familial disease in which hypercalcemia and nephrocalcinosis are associated with a defect in the intestinal transport of tryptophan
(Table 6). Bacterial degradation of

the tryptophan leads to excessive
indole production and, thus, to indicanuria, which, on oxidation to
indigo blue, causes peculiar bluish
discoloration of the diaper; hence,
the picturesque name.
Phenylketonuria
In phenylketonuria there also
may be a defect in absorption of
amino acids, at least as tested by
oral administration of arginine.
Figure 11 shows the appearance of
arginine in blood after feeding
labelled arginine to a patient with
phenylketonuria. The appearance
of the label in the serum was very
much delayed, and the radioactivity levels achieved were very much
lower than in a normal control subject. This is, at best, only preliminary suggestive evidence for malabsorption, since appearance curves
by themselves are subject to many
-29
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variables and cannot be taken entirely as indicating an amino acid
transport defect. That this defect
may, however, be a reversible phenomenon is demonstrated in Figure
12, where line A is the appearance
of radioactivity in the blood after
feeding of radioactive Ieucine in
a patient with phenylketonuria.
Line B shows the results of the
same test in the same subject after
a period of phenylalanine deprivation. Considerable improvement in
amino acid uptake is seen, matching the observation on the normal
control subject of the same age.
These data and other that have
been gathered in terms of the effect of phenylalanine on amino acid
transport into brain tissue suggest
that the abnormality leads to a
metabolic block of amino acid
transport which may be reversible
in nature.
Efject of Galactose on
Acid Transport

Amino

As a final example of a disorder in which amino acid transport by the gut may be affected,
the effect of galactose has been
studied. Table 7 shows that the
gut mucosa of rats, prefed 30%
galactose for several months, had
a diminished uptake of various
amino acids compared to control
values. Prefeeding rats with a
variety of other sugars such as
glucose, xylose, and ribose has no
effect, whereas prefeeding with
fructose has a minimal effect. The
possible implications for the human
disease, galactacemia, are evident.
Co nc lusio n
In concluding, it is of some
use to compare the criteria for
active and passive transport presented in Table 8. Although somewhat more sophisticated subdivisions of this table can be made,
I think it is useful to review the
data in this way. In active transport, the substance is transported
from a fluid of a lower concentration to that of a higher; passive
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Fig. 12-Specific activity (CPM/ ml) in serum after oral application of 3 H-LLeucine (23 µC/ kg )--------phenylketonuria patient 7 years, normal diet (A);
· · · · ·phenylketonuria, the same case, diet poor in phenylalanine (B);:---control subject, 3 years ( C) . (Translated from the German. Reprinted with
permission from Klin. Wochschr. 41:253, 1963.)
TABLE 7
Amino-Acid Transport by Jejuna! Slices from Rats Fed 30 Per Cent
D-Galactose for 2-3 Months
Distribution Ratios
Intestinal
Slices
Control
Galactose-fed
p

L-alanine

L-valine

Glycine

L-lysine

4.0 ± 0.6 4.2 ± 0.9 2. 3 ± 0.5 J.6 ± 0.4
2.8 ± 0.8 2.3 ± 0.3 l.5 ± 0.7 1.3 ± 0. 3
< 0.05
< 0.01
< 0.05
< 0.01

Hydroxy-Lpro line
1.9 ± 0.3
1.3 ± 0.5
< 0.05

Adapted with permission from Nature 205: 700, 1965.

diffusion movement is only from a
higher concentration to a lower.
The rate of transport is not necessarily related to molecular volume,
whereas in passive diffusion, by and
large, smaller molecules diffuse at
a greater rate. In active transport
there is stereospecificity, that is,
stereoisomers are generally transported less efficiently than the
naturally occurring compounds. It
suggests that there is a specific kind
of receptor site to which the transported molecule must be attached.
In active transport the rate of

transport is not proportional to the
concentration gradient. It shows
the saturation phenomenon at high
substrate concentrations. This
does not occur in passive diffusion .
In active transport one can show
competitive inhibition by related
compounds; the rate of transfer
is unaffected by the presence of
closely related compounds in passive diffusion. Transport rate is
reduced by metabolic poisons when
material is actively transported,
whereas the rate of transfer is not
greatly affected in passive diffusion

B. FLESHLER
RIDGE. The metabolic disorder in
Hartnup disease. Quart. J. Med.
29: 407-421, 1960.

TABLE 8
Comparison of Active Transport and Passive Diffusion
Active Transport
Relation to concentration Transport from fluids of a
gradient
lower to a higher concentration occurs
Relationship to apparent Speed of transport not
molecular volume in
necessarily related to apcompounds of similar
parent molecular volume
type
Stereospecificity
Stereospecific. Stereoisomers in general are transported less readily than
naturally occurring compounds
Rate of transfer not proSaturation of system at
high concentrations
portional to concentration
gradient. and approaches
a limiting maximal value
Competitive inhibition by Rate of transfer reduced
related compounds
by simultaneous transport
of a related compound
sharing the same transport system
Non-competitive
Transport reduced by
inhibition
metabolic poisons--e.g.
dinitrophenol

Passive Diffusion
Movement only from fluids
of a higher to a lower concentration
Smaller molecules in general diffuse at a greater rate

Rate of transfer of stereoisomers identical

Rate of transfer proportional to concentration
gradient and no limiting
maximal rate occurs
Rate of transfer unaffected
by the presence of closely
related compounds

SAUNDERS, S. J. AND K. J. ISSELBACHER.
Inhibition of intestinal amino-acid
transport by sugars. Nature 205:
700-701, 1965.
THIER, s., M. Fox, s. SEGAL, AND
L. E. ROSENBERG. Cystinuria: in
vitro demonstration of an intestinal
transport defect. Science 143: 482484, 1964.
WILSON, T. H . Intestinal Absorption.
Philadelphia: W. B. Saunders, 1962,
pp. 33, 123.
WISEMAN, G. Active transport of
amino acids by sacs of everted
small intestine of the golden
hamster (Mesocricetus auratas) . J.
Physiol. 133: 626- 630, 1956.

Rate of transfer not
affected unless obvious
cellular damage occurs

Reprinted with permission from Brit. Med. J. 1: 328, 1964.

unless cellular damage has occurred.
Thus, there are many characteristics by which one can attempt to
assess whether or not materials are
transported passively or require a
specific energy-dependent system
for their movement. There is reason to believe on the b asis of the
evidence presented here, on the
basis of in vitro studies with
everted gut sacs a nd other tissue
preparations, on the basis of physiologic perfusion studies, and, perhaps most significantly, on the
basis of studies in various disease
states with specific amino acid
transport defects, that amino acid
transport by the gut is an active
process which may be affected by a
variety of inhibitors in pathophysiologic states. We are just beginning
to understand the importance of
these defects in human metabolism.
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